101273
2-溴-4′-氯苯乙酮
98%
别名:
ω-溴-4-氯苯乙酮, 4-氯苯酰甲基溴
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
ClC6H4COCH2Br
化学文摘社编号:
分子量:
233.49
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
208-631-5
Beilstein/REAXYS Number:
607603
MDL number:
Assay:
98%
Form:
solid
产品名称
2-溴-4′-氯苯乙酮, 98%
InChI key
FLAYZKKEOIAALB-UHFFFAOYSA-N
InChI
1S/C8H6BrClO/c9-5-8(11)6-1-3-7(10)4-2-6/h1-4H,5H2
SMILES string
Clc1ccc(cc1)C(=O)CBr
assay
98%
form
solid
mp
93-96 °C (lit.)
functional group
bromo
chloro
ketone
Quality Level
正在寻找类似产品? 访问 产品对比指南
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
法规信息
新产品
此项目有
Daniel I Perez et al.
Journal of medicinal chemistry, 54(12), 4042-4056 (2011-04-20)
Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different tauopathies. Following
Shigeo Hayashi et al.
Journal of enzyme inhibition and medicinal chemistry, 29(6), 846-867 (2014-02-13)
Because of the pivotal role of cyclooxygenase (COX) in the inflammatory processes, non-steroidal anti-inflammatory drugs (NSAIDs) that suppress COX activities have been used clinically for the treatment of inflammatory diseases/syndromes; however, traditional NSAIDs exhibit serious side-effects such as gastrointestinal damage
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持